NewsRoom Articles - Page 231 of 606

ThursdayNov 04, 2021 4:20 am

420 with CNW — Florida Judge Rules That Ordering Medical Cannabis Online Is Legal

Last week, an administrative law judge issued a ruling stating that medical cannabis operators and patients who use medical cannabis in the state of Florida could resume selling and buying cannabis products online. Up until February of this year, most medical cannabis operators in the state relied on a popular e-commerce marijuana company I Heart Jane and Leafly to offer online shopping services to patients who use medical cannabis in Florida. However, state health officials prohibited these operators from using third-party sites such as Leafly to process medical cannabis patient orders, arguing that they were in violation of state laws…

WednesdayNov 03, 2021 4:20 pm

420 with CNW — Sustainability Drives Cannabis Beverage Makers to Adopt Eco-Friendly Packaging

After more than a century of industrialization, we are finally starting to own up to the repercussions of polluting the environment. The world is heating up to a dangerous degree, disrupting planetary cycles and causing extreme weather conditions around the globe. While the drive for sustainability and renewability didn’t pick up much steam before the 2010s, more and more companies are striving to reduce their carbon footprints as people become more conscious of the environmental effects of their favorite products. America’s state-legal cannabis industry hasn’t been left behind, with players that make cannabis beverages ditching traditional packaging options for ecofriendly…

WednesdayNov 03, 2021 1:44 pm

The Cannabis World Congress & Business Exposition (CWCBExpo) Is Set to Headline the New York Cannabis Week; Will Bring Together Hundreds of Businesses from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held in New York between November 4-6, 2021 The conference will feature over 50 expert speakers, in addition to hundreds of exhibitors showcasing the sector’s latest product innovations Recent forecasts have estimated overall US marijuana retail sales to rise from $20 billion in 2020 to $38.4-45.9 billion by 2025 The Cannabis World Congress & Business Exposition (“CWCBExpo”) event is set to be held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021. Set to be held during Cannabis Week, a weeklong event taking place between Monday…

WednesdayNov 03, 2021 12:38 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://cnw.fm/iMVe3). EPIL-A21-1, which will be…

WednesdayNov 03, 2021 4:20 am

420 with CNW — Senate Committee Asks State Department to Account for Funds Spent on Drug War

A recent report filed by top senators has asked the State Department to explain how the billions in funding that was injected into various counter-narcotics programs across Latin America were used, as these programs haven’t yielded results. The report also calls out the federal government over the failed war on drugs. The report is part of the bill to finance the federal government that Chairman Patrick Leahy of the Senate Appropriations Committee introduced a couple of days ago. The panel stated that the incidence of corruption and violence related to drug trafficking in Latin America has increased steadily since the…

TuesdayNov 02, 2021 4:20 pm

420 with CNW — Lung Cancer Case Report Triggers Calls for Additional Research on Cannabidiol

Although cannabidiol (“CBD”) has grown extremely popular over the past couple of years thanks to anecdotal user claims of medical efficacy, most scientists have been reluctant to say anything conclusive until they carry out more in-depth research. Users have claimed that CBD can be effective against pain, anxiety, depression, and insomnia; in limited circles, some even claim that the hemp extract can kill cancer cells. But as the research on CBD’s potential benefits and risks is limited and in its infancy, experts have cautioned against using CBD as an alternative to prescribed medication, especially when life-threatening conditions like cancer are…

TuesdayNov 02, 2021 12:59 pm

Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures’ 2020 revenue jumped 517% year-over-year to $14.6 million 2020 revenues from cannabis sales were $14.1 million, up 975% compared to fiscal 2019 The company’s gross profit spiked 483% year-over-year, reaching $2.78 million in 2020, while gross margins held steady at about 20 percent Cannabis Strategic Ventures will launch its first Los Angeles dispensary in Q4 2021 The company will open an indoor cultivation facility with capacity to produce up to 15,000 pounds of premium cannabis flower annually Cannabis Strategic Ventures (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator.…

TuesdayNov 02, 2021 4:20 am

420 with CNW — New York Cannabis Regulators to Allow Patients to Grow Medical Cannabis

The Cannabis Control Board in the state of New York has voted to allow medical marijuana patients to grow marijuana for personal use. The cannabis regulators plan to file the proposed regulations, which will permit patients who meet the criteria to grow up to six plants, either outdoors or indoors, for their own therapeutic use. Once the regulations have been published, the public will be afforded a 60-day comment period. After this, the board will review these comments and make any amendments they deem necessary, after which the regulations will be filed officially in order to take effect. The chair…

MondayNov 01, 2021 4:20 pm

420 with CNW — NIDA Tells Congress Drug Scheduling Is Hindering Cannabis Research

Marijuana’s federal classification as a Schedule I controlled substance has consistently been a thorn in the plant’s side, especially as more states have chosen to legalize it in various capacities. With the drug more accessible to the public than it has ever been thanks to state cannabis reform, a growing number of people have been using cannabis either medically or recreationally. As cannabis becomes even more popular among the masses, most experts agree that the hype around it and its purported medical abilities has far outpaced the science and that more research on marijuana’s potential benefits and risks is needed.…

MondayNov 01, 2021 1:49 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU,…

News and publishing service for cannabis related companies

Contact us: 512.354.7000